Epirubicin Plus Cyclophosphamide Followed by Docetaxel Versus Epirubicin Plus Docetaxel Followed by Capecitabine As Adjuvant Therapy for Node-Positive Early Breast Cancer: Results From the GEICAM/2003-10 Study
Identificadores
Identificadores
Fecha de publicación
2015Título de revista
Journal Of Clinical Oncology
Tipo de contenido
Artigo